SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PMCO - Promedco
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: silicon warrior who wrote (67)7/23/1998 3:46:00 PM
From: Joseph Strohsahl  Read Replies (1) of 106
 
Physician management company PhyCor (PHYC) fell 38 percent after reporting second-quarter earnings of 22 cents a share, in line with analysts' estimates. However, the company warned fiscal year 1998 earnings would be 10 percent below estimates. Shares fell 5 5/16 to 8 3/4.

7/21/98SECOND-QUARTER EPS OUTLOOKMIXED PERFORMANCE
HEADLINE: Second quarter EPS results for the physician practice management industry should be mixed. Several companies should post respectable earnings improvement over last year's quarter, but some others are expected to report lower or lackluster results. The large cap companies are experiencing significant challenges (MedPartners and PhyCor) and the lack of visibility on earnings has hurt these stocks. We remain cautious on the group and hence selective on the group, with American Oncology Resources and ProMedCo rated "Attractive."

If you ask me......I think PMCO fall is overdone
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News